Back
Bioday
Bioday
In 2018, the BioDay registry was launched. This is a registry for recording data on the use of new drugs in constitutional eczema in daily practice.
In the BioDay registry, we follow patients with constitutional eczema and examine the effectiveness, safety and patient satisfaction of new medications in daily practice. The BioDay registry is unique because patients from different parts of the Netherlands are followed up for at least 5 years. This makes it possible to answer a wide range of questions.